NEURAXIS, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
NEURAXIS, INC. (NRXS) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 7.45 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-11
- NEURAXIS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 8.06M shares, a 8.01% decline year-over-year.
- NEURAXIS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 8.76M shares, a 168.26% increase year-over-year.
- NEURAXIS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 3.27M shares, a 27.83% decline year-over-year.
- NEURAXIS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 4.52M shares.
- NEURAXIS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 6.50M shares, a 21.19% decline from fiscal 2024.
- NEURAXIS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 8.24M shares, a 162.37% increase from fiscal 2023.
- NEURAXIS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 3.14M shares, a 12.63% decline from fiscal 2022.
- NEURAXIS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 3.60M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 7.45M shares 10-Q · filed 2026-08-11 | ||||
| 2026-03-31 | 8.06M shares 10-Q · filed 2026-05-12 | ||||
| 2025-12-31 | 6.50M shares 10-K · filed 2026-03-19 | ||||
| 2025-09-30 | 7.82M shares 10-Q · filed 2025-11-10 | ||||
| 2025-06-30 | 7.75M shares 10-Q · filed 2026-08-11 | ||||
| 2025-03-31 | 8.76M shares 10-Q · filed 2026-05-12 | 8.76M shares 10-Q · filed 2025-05-12 | |||
| 2024-12-31 | 8.24M shares 10-K · filed 2026-03-19 | ||||
| 2024-09-30 | 5.30M shares 10-Q · filed 2025-11-10 | ||||
| 2024-06-30 | 3.49M shares 10-Q · filed 2025-08-12 | ||||
| 2024-03-31 | 3.27M shares 10-Q · filed 2025-05-12 | 3.18M shares 10-Q · filed 2024-05-20 | |||
| 2023-12-31 | 3.14M shares 10-K · filed 2025-03-20 | ||||
| 2023-09-30 | 3.11M shares 10-Q · filed 2024-11-12 | ||||
| 2023-06-30 | 4.99M shares 10-Q · filed 2024-08-09 | ||||
| 2023-03-31 | 4.52M shares 10-Q · filed 2024-05-20 | ||||
| 2022-12-31 | 3.60M shares 10-K · filed 2024-04-16 | ||||
| 2022-09-30 | 3.35M shares 10-Q · filed 2023-11-20 | ||||
| 2022-06-30 | 3.05M shares 10-Q · filed 2023-09-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |